TrialAnnals of the rheumatic diseases2014

Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2.

J Sieper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.